German construction sector still in recession, civil engineering only bright spot
Investing.com -- U.S. stock futures traded in tight ranges Monday, consolidating after recent record highs ahead of the conclusion of the latest two-day Federal Reserve policy meeting.
Here are some of the biggest premarket U.S. stock movers today:
-
Nvidia (NASDAQ:NVDA) stock fell 1.6% after China’s market regulator said it will extend its antitrust probe into the U.S. chipmaker after finding preliminary evidence the company breached the country’s competition law.
-
Apple (NASDAQ:AAPL) stock rose 1.1% after JP Morgan analysts said demand for the tech giant’s recently launched iPhone 17 line appears to be stronger than first-week demand seen for the 16 series last year, citing delivery lead-times in key markets.
-
Tesla (NASDAQ:TSLA) stock rose 7.2% after CEO Elon Musk purchased over 2.5 million shares in the electric vehicle manufacturer, according to a filing with the US Securities & Exchange Commission.
-
Intel (NASDAQ:INTC) stock gained 0.4% despite the chipmaker lowering its full-year 2025 adjusted operating expense target to $16.8 billion, from $17 billion earlier, to reflect the deconsolidation of its programmable chip business, Altera.
-
Warner Bros Discovery (NASDAQ:WBD) stock fell 0.5% after the entertainment giant handed back some of the more than 50% gains it has seen since reports emerged that Paramount Skydance was preparing a bid for the Hollywood studio.
-
Alaska Air (NYSE:ALK) stock dropped 0.6% after the carrier cut its third-quarter earnings guidance, citing elevated fuel costs and operational challenges during the summer, which have pressured unit costs.
-
AstraZeneca (NASDAQ:AZN) ADRs fell 1.8% after the drugmaker paused a planned £200 million ($271 million) investment in its Cambridge research hub.
-
Palo Alto Networks (NASDAQ:PANW) stock rose 0.7% after Wedbush added the cybersecurity company to its “Best Ideas” list, adding to the 10% gain already over the course of the month.
-
Hims Hers Health (NYSE:HIMS) stock fell 2.8% after FDA Commissioner Marty Makary said a widely watched TV commercial by the telehealth firm earlier this year breached the agency’s regulations.